Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut
Open accessThe DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
Abstract
The pathogenesis of inflammatory bowel disease (IBD) is multifactorial with data suggesting the role of a disturbed interaction between the gut and the intestinal microbiota. A defective mucosal barrier may result in increased intestinal permeability which promotes the exposition to luminal content and triggers an immunological response that promotes intestinal inflammation. IBD patients display several defects in the many specialized components of mucosal barrier, from the mucus layer composition to the adhesion molecules that regulate paracellular permeability. These alterations may represent a primary dysfunction in Crohn's disease, but they may also perpetuate chronic mucosal inflammation in ulcerative colitis. In clinical practice, several studies have documented that changes in intestinal permeability can predict IBD course. Functional tests, such as the sugar absorption tests or the novel imaging technique using confocal laser endomicroscopy, allow an in vivo assessment of gut barrier integrity. Antitumor necrosis factor-α (TNF-α) therapy reduces mucosal inflammation and restores intestinal permeability in IBD patients. Butyrate, zinc, and some probiotics also ameliorate mucosal barrier dysfunction but their use is still limited and further studies are needed before considering permeability manipulation as a therapeutic target in IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Confocal laser endomicroscopy images from a healthy subject (a) and an Ulcerative Colitis (UC) patient with inactive disease (b). UC patients display increased crypt diameter, intercryptic distance, and perivascular fluorescence. Courtesy of Dr. A. Buda and with permission of Journal of Crohn's and Colitis [105]; © inclusion under a Creative Commons license or any other open-access license allowing onward reuse is prohibited.](https://figures.cochat.ai/paper-figures/2164d4b5b56e4db78a431b3045efb19f/intestinal-permeability-in-inflammatory-bowel-disease-pathogenesis-clinical-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This condition, known as intestinal permeability or leaky gut, has been implicated in the pathophysiology of various GI, as well as extraintestinal disorders [120,121,122], including PD [117,123,124,125,126,127,128]”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [121]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591 · cited 5×
“As a matter of fact several defects in bacterial recognition and processing have been documented in CD patients carrying particular genetic polymorphisms, chiefly of pattern-recognition receptors such as NOD2/CARD15 [68, 69] and genes involved in autophagy like ATG16L1 and IRGM [70–72].”
BackgroundInfluentialA frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 1×
“[9] “permeability” is defined as a functional feature of this barrier that on one hand allows the coexistence with bacterial symbionts necessary for our organism and on the other hand prevents luminal penetration of macromolecules and pathogens [10, 11].”
BackgroundReview article: the role of butyrate on colonic function
HAMER, H. M., JONKERS, D., VENEMA, K., VANHOUTVIN, S., TROOST, F. J., & BRUMMER, R. ‐. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03562.x · Cited by 2,721
Genetics and pathogenesis of inflammatory bowel disease
Khor, B., Gardet, A., & Xavier, R. J. (2011) · Nature · doi:10.1038/nature10209 · Cited by 2,614
MICROBIAL ECOLOGY OF THE GASTROINTESTINAL TRACT
Savage, D. C. (1977) · Annual Review of Microbiology · doi:10.1146/annurev.mi.31.100177.000543 · Cited by 2,436 · cited 1×
“It is estimated that the total bacterial cell count in our body exceeds ten times the total number of human cells, with more than one thousand species hosted in the gastrointestinal tract [1, 2].”
BackgroundMachiels, K., Joossens, M., Sabino, J., De Preter, V., Arijs, I., Eeckhaut, V., Ballet, V., Claes, K., Van Immerseel, F., Verbeke, K., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304833 · Cited by 1,904 · cited 1×
“Another potential mechanism of action is the restoration of butyrate-producing bacteria: UC patients have reduced bacterial species like Faecalibacterium prausnitzii [133, 139] and supplementation with butyrate-producing species or probiotics along with preformed butyrate showed efficacy in experimental models [140, 1…”
BackgroundHampe, J., Franke, A., Rosenstiel, P., Till, A., Teuber, M., Huse, K., Albrecht, M., Mayr, G., De La Vega, F. M., Briggs, J., et al. (2007) · Nature Genetics · doi:10.1038/ng1954 · Cited by 1,897
Intestinal barrier function: molecular regulation and disease pathogenesis
Groschwitz, K. R., & Hogan, S. P. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.05.038 · Cited by 1,775 · cited 1×
“The mechanical cohesion of these cells and the regulation of paracellular permeability of ions and smallmolecules are ensured by three types of junctional complexes, namely, tight junctions (TJs), adherence junctions, and desmosomes [24, 26, 27].”
BackgroundIntestinal permeability – a new target for disease prevention and therapy
Bischoff, S. C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J.-D., Serino, M., Tilg, H., Watson, A., & Wells, J. M. (2014) · BMC Gastroenterology · doi:10.1186/s12876-014-0189-7 · Cited by 1,755 · cited 6×
“Both the probes are equally affected by gastrointestinal dilution, motility, bacterial degradation, and renal function; thus, the ratio allows for correcting possible confounding factors [9, 82].”
BackgroundInfluential
Research works printed but not linked: 1
- D'Incà R. Di Leo V. Martines D. Can permeability to sugars predict relapses in Crohn's disease? Gut 1993 34 1, supplement S50 S73
Cited by
Items 701–759 of 759
Teissier, T. (2019) · theses.fr (ABES) · doi:10.70675/f49bc069z5ee6z4c49zb46fz0a1413dbba95
Role of macrophages in colon homeostasis
Chikina, A. S. (2020) · theses.fr (ABES) · doi:10.70675/914bf102zc92ez4351zb4dbz1945d4116eea
Les cellules MAIT et la riboflavine dans les interactions hôte-microbiote
Morr, Y. E. (2021) · theses.fr (ABES) · doi:10.70675/c6a9fb38zefecz4f2ez8e2fz84c7e5f828dc
Chervy, M. (2022) · theses.fr (ABES) · doi:10.70675/54cc9c5dzcd68z4172za033z1cc37151cbf0 · Cited by 1
Mariaule, V. (2024) · theses.fr (ABES) · doi:10.70675/1d41e841zf788z4dd7z8784zc26304e24ea1
Fioroni, N. (2023) · theses.fr (ABES) · doi:10.70675/f1f99961zc559z4ae5z9228z0f4b3dc9e4fe
Fargeas, M. (2024) · theses.fr (ABES) · doi:10.70675/cde34172z075cz4f4dza628z2707ac1ec2b7
Villegas-Novoa, C., Wang, Y., Wang, H., Jan, I., Sims, C. E., & Allbritton, N. L. (2026) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c02107
Husnoo, N., Whitman, A., Morgan, J. L., Wyld, L., Lobo, A., & Brown, S. R. (2026) · Frontline Gastroenterology · doi:10.1136/flgastro-2025-103572
Ding, Y., Zhang, J., Zou, Y., Tang, L., Liu, Y., Pu, L., Guo, X., Li, W., & Wang, S. (2026) · The FASEB Journal · doi:10.1096/fj.202504557r
“Moreover, intestinal barrier dysfunction increases intestinal permeability, which correlates with the severity of IBD [3].”
Epithelial NCAPD3 expression protects against stress-induced intestinal injury in micePreprint
Johnston, I., Johnson, E. E., Khan, A. O., Longworth, M. S., & McDonald, C. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.21.719792
Zhou, J., Lu, J., Feng, C., Sun, F., Nie, M., Yang, R., Kwok, L. Y., He, Q., & Zhong, Z. (2026) · Food Science and Human Wellness · doi:10.26599/fshw.2026.9251056
Oral microbiota and gastroenterological diseases
Трухан, Д. И., Rozhkova, M. Y., Филиппович, С. А., & Trukhan, L. Y. (2026) · Medical alphabet · doi:10.33667/2078-5631-2026-5-7-15
Hu, X., Chen, J., Zhou, Y., Ji, X., Shen, S., Qian, J., Li, T., Xu, F., Zhou, Y., Zhou, D., et al. (2026) · Digestive Diseases and Sciences · doi:10.1007/s10620-026-09960-0
Arinno, A., Sukmak, P., Treveeravoot, S., Kulworasreth, P., Supapol, P., Sangsuwan, W., Teansuk, N., Wachiradejkul, W., Inchai, J., Sricharunrat, T., et al. (2026) · Biological Research · doi:10.1186/s40659-026-00696-9 · Cited by 1
Gould, A. A. M., Walsh, N. P., Tipton, M., Zurawlew, M. J., Robson, S. C., Shute, J. K., Watts, J. E. M., Tyson, H. C., Robinson, M. R., Roberts, A. J., et al. (2026) · Experimental Physiology · doi:10.1113/ep093100 · Cited by 2
“Whilst non-steroidal anti-inflammatory drug (NSAID) use (Rogers & Aronoff, 2016) and GI disorders (Michielan & D’Incà, 2015) may affect the GI microbiota, we elected not to exclude NSAID users and individuals reporting a GI disorder (either as cases or non-EHI controls) from our participant pool…”
Molecular mechanisms of persistence of adherent-invasive Escherichia coli in the host organism
Pobeguts, O. V., Avshalumov, A. S., Mikhailycheva, M. V., & Gorbachev, A. Y. (2026) · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · doi:10.29413/abs.2026-11.2.8
Pieszka, M., Szczepanik, K., Lepczyński, A., Marynowska, M., Oczkowicz, M., Ozgo, M., Łoniewski, I., Orczewska‐Dudek, S., Adaszyńska-Skwirzyńska, M., Śliwiński, B., et al. (2026) · Nutrients · doi:10.3390/nu18111784
“This perspective overshadowed the crucial role of commensal microorganisms in maintaining host health and supporting gut integrity [6,7].”
Kareem, R. A., Ibrahim, A. S., & Saleh, A. M. (2026) · Advanced medical journal · doi:10.56056/amj.2026.458
Stein, R. A., Ganesh, A., Rianom, N. A., & Paratore, A. W. (2026) · Physiological Genomics · doi:10.1152/physiolgenomics.00230.2025
Gbati, L., Rodríguez‐Sojo, M. J., Molina‐Tijeras, J. A., García-García, J., López-Escánez, L., Vezza, T., Ruiz‐Malagón, A. J., Djeri, B., García, F., Gálvez, J., et al. (2026) · Nutrients · doi:10.3390/nu18121890
“A hallmark of DSS-induced colitis is the profound loss of epithelial integrity and mucus layer disruption, which facilitates bacterial translocation and subsequently amplifies mucosal inflammation [23,24].”
Caballero, V., Estévez, M., Sánchez-Terrón, G., Morcuende, D., & Martínez, R. (2026) · Food Chemistry · doi:10.1016/j.foodchem.2026.150117
Микробиота полости рта и гастроэнтерологические заболевания
Трухан, Д. И., Рожкова, М. В., Филиппович, С. А., & Трухан, Л. Ю. (2026) · Medical alphabet
Hall, R., Colwill, M., Patel, K., Honap, S., & Poullis, A. P. (2026) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.122786
“Tight junctions play a crucial role in regulating the passage of nutrients and other luminal contents whilst preventing entry of pathogens and toxins[83].”
REG3A: A Potential Fecal Biomarker for Ulcerative Colitis
Lv, X., Qi, Y., Guo, J., Ba, L., Wang, S., Cao, H., & Xu, X. (2026) · Mediators of Inflammation · doi:10.1155/mi/9316792
The dietary restoration of intestinal barrier function by nutrient-sensing receptors
Arinno, A., & Pongkorpsakol, P. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40306-4.00014-4
Bai, X., Ihara, E., & Akiho, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40306-4.00016-8
Grondin, J. A., Wang, H., Haq, S., Cheng, C., Derakhshani, H., MacNeil, L. T., Surette, M. G., & Khan, W. I. (2026) · Scientific Reports · doi:10.1038/s41598-026-60105-9
Lan, X., Cao, J., Qu, Y., Chunyang, X. I. A., Zhu, L., Yang, L., & Ding, D. (2026) · Aging Research · doi:10.26599/agr.2026.9340077
Changes in cytokine expression in pediatric patients with juvenile arthritides and Crohnʼs disease
Meleshkina, А. V., Soboleva, A. G., Mezentsev, A., Sobolev, V. V., Chebysheva, S. N., Geppe, N. A., & Korsunskaya, I. M. (2026) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2026-225
Boumessid, K., Lacroix, V., Ovtchinnikova, E., Thenet, S., Carrière, M., Barreau, F., & Mas, E. (2026) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/jpn3.70517
Rodríguez-Ramírez, R. (2026) · Institutional Repository of the University of Granada (University of Granada)
O’Brien, K., & Blair, P. (2026) · Springer eBooks · doi:10.1007/978-3-032-14521-5_10
Qiao, C., Yuan, X., Li, T., Song, T., Ling, Y., Chui, Y., & Song, X. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108779
Gómez, D. P. (2021) · Knowledge UdeS (Institutional Deposit of the University of Sherbrooke)
Singh, D., Achanta, A., Menghini, P., Wong, K., Delffs, H., Rodriguez‐Palacios, A., Martino, L. D., Cominelli, F., & Basson, A. R. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11166-9
Li, X., Fan, W., Chen, W., Wu, B., Chen, L., Wu, A., & Wang, X. (2026) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6c13980
Erdoğan, K., Özsoy, Ö., Aksu, S., Özbey, Ö., Korkmaz, G., Izgut-Uysal, V. N., & Birsen, İ. (2026) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/s44411-026-00827-4
Alam, S., Shaughnessy, C. A., Lucas, E. A., Olawale, F., Fathepure, B. Z., & McCullagh, E. A. (2026) · mSphere · doi:10.1128/msphere.00442-26
AlMalki, M., Pierri, C. R. D., Méric, T., Mkaouar, H., Slimani, D., Mariaule, V., Tebassi, S., Akermi, N., Maguin, E., Hernandez, J. L., et al. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2726641
Azamar, K. M. M., Rajesh, K., Garner, J., Downing, B., Javith, M., Yamhure, I., & Porras, A. M. (2026) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-026-00938-6
Strategie antifibrotiche in modelli in vitro e in vivo di malattia infiammatoria intestinale
Artone, S. (n.d.) · Archivio Istituzionale della Ricerca - Università degli Studi dell Aquila · Cited by 1
Zhang, L. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02426-9
Khan, A., Ray, G., Musich, R. J., Selmi, I., Gjojdeshi, A., Talley, M. J., Oliver, J., Bashaar, A., Rayan, C., Fulmer, C. G., et al. (2026) · iScience · doi:10.1016/j.isci.2026.117884
The intestinal microbiome in inflammatory bowel disease and spondyloarthritides
Alizadeh, M. A., Siaton, B. C., Hudhud, D. N., von Rosenvinge, E. C., Cross, R. K., & Ravel, J. (2026) · Communications Medicine · doi:10.1038/s43856-026-01919-6
Geng, C., Liu, Y., Li, Y., Xie, X., Guo, Y., Liu, J., Li, X., & Wang, C. (2026) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2026.10.006
Lan, J., Li, C., Huang, S., Wang, J., Fan, K., Chang, J., Xue, C., Hao, Z., & Ma, Y. (2026) · Food Science and Human Wellness · doi:10.26599/fshw.2026.9251284
Обзор эффективности кормовых добавок «ПроВетин для птиц» и «Клювер Про +» в животноводстве
Ренатович, Г. Р. (n.d.) · CyberLeninK (CyberLeninka)
Metadata
- Authors
- Michielan, A., & D’Incà, R.
- Affiliations
- University of Padua (IT)
- Corresponding author
- Michielan, Andrea
- ORCID
- Michielan, Andrea
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2015-01
- Volume
- 2015
- Issue
- 1
- Pages
- 628157-628157
- ISSN
- 0962-9351 (ISSN-L)
- 1466-1861
- PMC
- PMC4637104
- OpenAlex
- W2176502392
- Cited by
- 709
- References
- 146
- Citations by year
- 2026: 61 · 2025: 54 · 2024: 86 · 2023: 91 · 2022: 99 · 2021: 82 · 2020: 81 · 2019: 58 · 2018: 38 · 2017: 37 · 2016: 21
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Mediators of Inflammation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- University of Oxford
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- intestinal permeability, leaky gut, inflammatory bowel disease, Crohn's disease, ulcerative colitis, mucosal barrier dysfunction, gut microbiota, mucus layer, paracellular permeability, adhesion molecules, confocal laser endomicroscopy, butyrate, zinc, probiotics, intestinal inflammation
- MeSH terms
- Humans, Intestinal Mucosa, Permeability, Tumor Necrosis Factor-alpha, Zinc, Inflammatory Bowel Diseases, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.